The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 15, 2020

Filed:

Oct. 31, 2017
Applicant:

The U.s.a., As Represented BY the Secretary, Department of Health and Human Services, Bethesda, MD (US);

Inventors:

John A. Chiorini, Dayton, MD (US);

Hongen Yin, Bethesda, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); G01N 33/68 (2006.01); A61K 31/519 (2006.01); A61K 38/17 (2006.01); C07K 16/22 (2006.01); C12N 15/113 (2010.01); C12N 15/115 (2010.01); C12Q 1/6883 (2018.01); G01N 33/74 (2006.01);
U.S. Cl.
CPC ...
A61K 49/0004 (2013.01); A61K 31/519 (2013.01); A61K 38/177 (2013.01); A61K 38/179 (2013.01); C07K 16/22 (2013.01); C12N 15/115 (2013.01); C12N 15/1136 (2013.01); C12Q 1/6883 (2013.01); G01N 33/6872 (2013.01); G01N 33/6893 (2013.01); G01N 33/74 (2013.01); C07K 2317/622 (2013.01); C07K 2317/76 (2013.01); C12N 2320/30 (2013.01); G01N 2333/4704 (2013.01); G01N 2333/51 (2013.01); G01N 2800/101 (2013.01);
Abstract

The finding that patients with Sjögren's syndrome exhibit a statistically significant increase in expression of BMP6 in the salivary gland relative to healthy control subjects is described. Also described is the finding that overexpression of BMP6 in the salivary glands of mice results in an increase in electrical potential across the salivary gland. Thus, methods of diagnosing a subject as having Sjögren's syndrome, or at risk for developing Sjögren's syndrome, by measuring the level of BMP6 expression in a salivary gland of a subject, measuring electrical potential in a salivary gland of a subject, or both, are disclosed. Also described are methods of treating a subject with Sjögren's syndrome by administering an agent that inhibits expression of BMP6 expression or activity. Further disclosed is the use of XIST and MECP2 as diagnostic and therapeutic targets for male Sjögren's syndrome patients.


Find Patent Forward Citations

Loading…